GB201502591D0 - Antibodies - Google Patents
AntibodiesInfo
- Publication number
- GB201502591D0 GB201502591D0 GB201502591A GB201502591A GB201502591D0 GB 201502591 D0 GB201502591 D0 GB 201502591D0 GB 201502591 A GB201502591 A GB 201502591A GB 201502591 A GB201502591 A GB 201502591A GB 201502591 D0 GB201502591 D0 GB 201502591D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201502591A GB201502591D0 (en) | 2015-02-16 | 2015-02-16 | Antibodies |
US15/550,903 US10953106B2 (en) | 2015-02-16 | 2016-02-15 | Antibodies |
SG10202006863YA SG10202006863YA (en) | 2015-02-16 | 2016-02-15 | Cl and/or ch1 mutated antibodies for drug conjugation |
CN201680010400.8A CN107207582A (en) | 2015-02-16 | 2016-02-15 | CL and/or CH1 mutant antibodies for drug conjugate |
EP20212421.0A EP3878861A1 (en) | 2015-02-16 | 2016-02-15 | Cl and/or ch1 mutated antibodies for drug conjugation |
KR1020177025612A KR20170116144A (en) | 2015-02-16 | 2016-02-15 | Antibodies for CL and / or CH1 mutagenic drug conjugation |
JP2017561034A JP6932649B2 (en) | 2015-02-16 | 2016-02-15 | Antibodies for drug conjugation with mutated CL and / or CH1 |
SG11201706292SA SG11201706292SA (en) | 2015-02-16 | 2016-02-15 | Cl and/or ch1 mutated antibodies for drug conjugation |
PCT/EP2016/053162 WO2016131769A2 (en) | 2015-02-16 | 2016-02-15 | Antibodies |
EP16704624.2A EP3259285A2 (en) | 2015-02-16 | 2016-02-15 | Cl and/or ch1 mutated antibodies for drug conjugation |
US17/019,537 US11833222B2 (en) | 2015-02-16 | 2020-09-14 | CL and/or CH1 mutated antibodies for drug conjugation |
JP2021132251A JP7439024B2 (en) | 2015-02-16 | 2021-08-16 | Antibodies for drug conjugation in which CL and/or CH1 are mutated |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201502591A GB201502591D0 (en) | 2015-02-16 | 2015-02-16 | Antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201502591D0 true GB201502591D0 (en) | 2015-04-01 |
Family
ID=52781694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201502591A Ceased GB201502591D0 (en) | 2015-02-16 | 2015-02-16 | Antibodies |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201502591D0 (en) |
-
2015
- 2015-02-16 GB GB201502591A patent/GB201502591D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1253507A1 (en) | Anti-ror1 antibodies | |
HK1254836A1 (en) | Anti-ror1 antibodies | |
HK1256116A1 (en) | Anti-lag-3 antibodies | |
GB201521391D0 (en) | Antibodies | |
GB201521393D0 (en) | Antibodies | |
HK1246804A1 (en) | Tau-binding antibodies | |
ZA201705663B (en) | Anti-transthyretin antibodies | |
GB201521382D0 (en) | Antibodies | |
ZA201705662B (en) | Anti-transthyretin antibodies | |
IL255323A0 (en) | Anti-fcrn antibodies | |
HK1255056A1 (en) | Anti-cd115 antibodies | |
SG11201706126WA (en) | Anti-transthyretin antibodies | |
GB201509907D0 (en) | Antibodies | |
GB201522394D0 (en) | Antibodies | |
GB201503438D0 (en) | Antibodies | |
IL284022B1 (en) | Anti-transthyretin antibodies | |
GB201518728D0 (en) | Antibodies | |
GB201515572D0 (en) | Anti-LAG-3 antibodies | |
GB201515570D0 (en) | Anti-LAG-3 antibodies | |
GB201514425D0 (en) | Antibodies | |
GB201508444D0 (en) | Antibodies | |
GB201508437D0 (en) | Antibodies | |
GB201507541D0 (en) | Antibodies | |
GB201504858D0 (en) | Antibodies | |
GB201502591D0 (en) | Antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |